|
|
|
|
||
Latest MNKD Bi-Wkly. Short Interest Down Again 5.17%, With Its Price Up 1.39%, As of 12-31-21MNKD's short interest fell again, from 20.338 M shares to 19.287 M shares, or 5.17%, between 12-15-21 and 12-31-21. During the same period, its price only rose from $4.31 to $4.37, or 1.39%. The current selling of biotech stocks is apparently making it easier to cover the short interest of biotechs, as we are now down below $4.00, at least temporarily. JMHO. P.S. If the FDA can approve Liquidia's inhaled Trepostinil powder, why can't it approve UTHR's inhaled Trepostinil powder?? Just wondering. |
return to message board, top of board |